IV Iron (standard of care)

DRUG2 trials

Sponsors

American Regent, Inc., Nicoletta C Machin

Conditions

BleedingBleeding DisordersIronIron Deficiency AnemiaPlatelet

Phase 3

Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)

CompletedNCT00982007

American Regent, Inc.Iron Deficiency Anemia

Start: 2009-09-30End: 2011-08-31Updated: 2018-02-20

Unknown Phase

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders

RecruitingNCT07083583

Nicoletta C MachinBleeding, Bleeding Disorders, Iron +1

Start: 2025-08-08End: 2027-10-01Target: 40Updated: 2025-10-03